한빛사논문
Abstract
Estelle Marion1, 2, 13, Ok-Ryul Song1, 2, 3, 13, Thierry Christophe2, 13, Jeremie Babonneau2, Denis Fenistein2, Joel Eyer4, Frank Letournel4, Daniel Henrion5, Nicolas Clere6, Vincent Paille5, Nathalie C. Guerineau5, Jean-Paul Saint Andre7, Philipp Gersbach8, Karl-Heinz Altmann8, Timothy Paul Stinear9, Yannick Comoglio10, Guillaume Sandoz10, Laurence Preisser11, Yves Delneste11, Edouard Yeramian12, 14, Laurent Marsollier1, 2, 11, 14, Priscille Brodin2, 3, 14
1 Inserm Avenir, 4 rue Larrey 49, 933 Angers, France
2 Inserm Avenir, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 Beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do 463-400, Korea
3 Inserm U1019, CNRS UMR8204, Universite de Lille - Nord de France, Institut Pasteur de Lille, Center for Infection and Immunity, 1, rue du Professeur Calmette, 59000 Lille, France
4 UPRES - EA 3143, Laboratoire de Neurobiologie et Transgenese, 4 rue Larrey 49, 933 Angers, France
5 Inserm 1083, CNRS UMR6214, Laboratoire de Biologie Neurovasculaire et Mitochondriale Integree, 4 rue Larrey 49, 933 Angers, France
6 Inserm U1063, Stress Oxydant et Pathologies Metaboliques, 4 rue Larrey 49, 933 Angers, France
7 Laboratoire d’anatomie pathologique, 4 rue Larrey 49, 933 Angers, France
8 ETH Zurich, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, Wolfgang-Pauli-Str. 10, 8093 Zurich, Switzerland
9 Department of Microbiology and Immunology, University of Melbourne, Parkville 3010, Australia
10 Inserm Avenir, Laboratories of Excellence, Ion Channel Science and Therapeutics Nice, Institut de Biologie Valrose, iBV, Inserm U1091, CNRS UMR7277, Universite Nice Sophia Antipolis, Parc Valrose, 06108 Nice, France
11 Equipe 7, Inserm U892, CNRS U6299, Universite et CHU, CRCNA, 4 rue Larrey 49, 933 Angers, France
12 Unite de Bioinformatique Structurale, CNRS UMR3528 Institut Pasteur, 75015 Paris, France
13 Co-first authors
14 Co-senior authors
Corresponding author : Laurent Marsollier, Priscille Brodin
Summary
Mycobacterium ulcerans, the etiological agent of Buruli ulcer, causes extensive skin lesions, which despite their severity are not accompanied by pain. It was previously thought that this remarkable analgesia is ensured by direct nerve cell destruction. We demonstrate here that M. ulcerans-induced hypoesthesia is instead achieved through a specific neurological pathway triggered by the secreted mycobacterial polyketide mycolactone. We decipher this pathway at the molecular level, showing that mycolactone elicits signaling through type 2 angiotensin II receptors (AT2Rs), leading to potassium-dependent hyperpolarization of neurons. We further validate the physiological relevance of this mechanism with in vivo studies of pain sensitivity in mice infected with M. ulcerans, following the disruption of the identified pathway. Our findings shed new light on molecular mechanisms evolved by natural systems for the induction of very effective analgesia, opening up the prospect of new families of analgesics derived from such systems.
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기